{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:55:43Z","timestamp":1787259343485,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072826"],"award-info":[{"award-number":["82072826"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cellsig.2025.112259","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T14:55:52Z","timestamp":1763650552000},"page":"112259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["COL1A1 promotes clear cell renal cell carcinoma progression through the Wnt\/\u03b2-catenin signaling pathway"],"prefix":"10.1016","volume":"138","author":[{"given":"Xing","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyang","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenpeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjian","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellsig.2025.112259_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112259_bb0010","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.1038\/s41598-024-61748-2","article-title":"A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000-2020","volume":"14","author":"Mousavi","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112259_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cellsig.2025.112259_bb0020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur. J. Cancer (Oxford, England\u202f: 1990)"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112259_bb0025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","article-title":"International variations and trends in renal cell carcinoma incidence and mortality","volume":"67","author":"Znaor","year":"2015","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112259_bb0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112259_bb0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.euf.2020.12.020","article-title":"A global trend analysis of kidney cancer incidence and mortality and their associations with smoking, alcohol consumption, and metabolic syndrome","volume":"8","author":"Huang","year":"2022","journal-title":"Eur. Urol. Focus"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112259_bb0040","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.annonc.2024.05.537","article-title":"Renal cell carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"35","author":"Powles","year":"2024","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112259_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","article-title":"Kidney cancer, version 3.2022","volume":"20","author":"Motzer","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"17","key":"10.1016\/j.cellsig.2025.112259_bb0050","article-title":"Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma: 5-year analysis of KEYNOTE-426","volume":"41","author":"Rini","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112259_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009495","article-title":"Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214","volume":"12","author":"Mantia","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cellsig.2025.112259_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154013","article-title":"COL1A1: a novel oncogenic gene and therapeutic target in malignancies","volume":"236","author":"Li","year":"2022","journal-title":"Pathol. Res. Pract."},{"issue":"Pt 12","key":"10.1016\/j.cellsig.2025.112259_bb0065","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1242\/jcs.03453","article-title":"Collagens at a glance","volume":"120","author":"Kadler","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellsig.2025.112259_bb0070","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.11145","article-title":"COL1A1 is a prognostic biomarker and correlated with immune infiltrates in lung cancer","volume":"9","author":"Geng","year":"2021","journal-title":"PeerJ"},{"issue":"19","key":"10.1016\/j.cellsig.2025.112259_bb0075","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.7150\/jca.59723","article-title":"Collagen type 1 alpha 1 chain is a novel predictive biomarker of poor progression-free survival and chemoresistance in metastatic lung cancer","volume":"12","author":"Hou","year":"2021","journal-title":"J. Cancer"},{"issue":"15","key":"10.1016\/j.cellsig.2025.112259_bb0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.14715\/cmb\/2023.69.15.21","article-title":"Expression, prognostic value and potential immunotherapeutic target of COL1A1 in colon cancer","volume":"69","author":"Zeng","year":"2023","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112259_bb0085","first-page":"5037","article-title":"COL1A1 promotes metastasis in colorectal cancer by regulating the WNT\/PCP pathway","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112259_bb0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12957-016-1056-5","article-title":"Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer","volume":"14","author":"Li","year":"2016","journal-title":"World J. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112259_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2022.06.011","article-title":"Oncogenic collagen I homotrimers from cancer cells bind to \u03b13\u03b21 integrin and impact tumor microbiome and immunity to promote pancreatic cancer","volume":"40","author":"Chen","year":"2022","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112259_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112259_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060786","article-title":"Collagen 1A1 (COL1A1) is a reliable biomarker and putative therapeutic target for hepatocellular carcinogenesis and metastasis","volume":"11","author":"Ma","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112259_bb0110","doi-asserted-by":"crossref","first-page":"20220776","DOI":"10.1515\/biol-2022-0776","article-title":"Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer","volume":"18","author":"Ma","year":"2023","journal-title":"Open Life Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112259_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112153","article-title":"Microenvironment remodeled by tumor and stromal cells elevates fibroblast-derived COL1A1 and facilitates ovarian cancer metastasis","volume":"394","author":"Li","year":"2020","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112259_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101279","article-title":"Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha V promotes invasion and metastasis of cholangiocarcinoma cells","volume":"29","author":"Pan","year":"2024","journal-title":"Ann. Hepatol."},{"issue":"15","key":"10.1016\/j.cellsig.2025.112259_bb0125","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.18632\/aging.102152","article-title":"Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers","volume":"11","author":"Chen","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cellsig.2025.112259_bb0130","article-title":"Identification of a metastasis-associated gene signature of clear cell renal cell carcinoma","volume":"11","author":"Gao","year":"2020","journal-title":"Front. Genet."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112259_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1339","article-title":"Hsa_circ_0057105 modulates a balance of epithelial-mesenchymal transition and ferroptosis vulnerability in renal cell carcinoma","volume":"13","author":"Cen","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cellsig.2025.112259_bb0140","article-title":"What mediates fibrosis in the tumor microenvironment of clear renal cell carcinoma","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Genet."},{"issue":"43","key":"10.1016\/j.cellsig.2025.112259_bb0145","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112259_bb0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","article-title":"Cellpose: a generalist algorithm for cellular segmentation","volume":"18","author":"Stringer","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cellsig.2025.112259_bb0155","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fonc.2020.00625","article-title":"Impact of extracellular matrix components to renal cell carcinoma behavior","volume":"10","author":"Majo","year":"2020","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112259_bb0160","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/annonc\/mdw652","article-title":"Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes","volume":"28","author":"Ho","year":"2017","journal-title":"Ann. Oncol."},{"issue":"23","key":"10.1016\/j.cellsig.2025.112259_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13235873","article-title":"The extracellular matrix environment of clear cell renal cell carcinoma determines cancer associated fibroblast growth","volume":"13","author":"Bond","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cellsig.2025.112259_bb0170","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112259_bb0175","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112259_bb0180","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cellsig.2025.112259_bb0185","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3389\/fonc.2020.00850","article-title":"CircCSPP1 functions as a ceRNA to promote colorectal carcinoma cell EMT and liver metastasis by upregulating COL1A1","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2025.112259_bb0190","doi-asserted-by":"crossref","first-page":"8963","DOI":"10.2147\/OTT.S259033","article-title":"circKRT7-miR-29a-3p-COL1A1 Axis promotes ovarian cancer cell progression","volume":"13","author":"An","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112259_bb0195","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2174\/1568009614666140402105101","article-title":"The activation of \u03b21-integrin by type I collagen coupling with the hedgehog pathway promotes the epithelial-mesenchymal transition in pancreatic cancer","volume":"14","author":"Duan","year":"2014","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.cellsig.2025.112259_bb0200","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.2147\/OTT.S194568","article-title":"Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer","volume":"12","author":"Zhu","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"10","key":"10.1016\/j.cellsig.2025.112259_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047649","article-title":"WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT\/\u03b2-catenin pathway","volume":"7","author":"Hsu","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112259_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8060057","article-title":"Wnt Signaling in renal cell carcinoma","volume":"8","author":"Xu","year":"2016","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112259_bb0215","doi-asserted-by":"crossref","first-page":"10944","DOI":"10.3390\/ijms140610944","article-title":"Impact of an altered Wnt1\/\u03b2-catenin expression on clinicopathology and prognosis in clear cell renal cell carcinoma","volume":"14","author":"Kruck","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.cellsig.2025.112259_bb0220","doi-asserted-by":"crossref","first-page":"19064","DOI":"10.18632\/aging.203355","article-title":"Type I collagen promotes tumor progression of integrin \u03b21 positive gastric cancer through a BCL9L\/\u03b2-catenin signaling pathway","volume":"13","author":"Lv","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112259_bb0225","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112259_bb0230","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112259_bb0235","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1084\/jem.20140692","article-title":"Fibroblast heterogeneity in the cancer wound","volume":"211","author":"\u00d6hlund","year":"2014","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112259_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2021.03.007","article-title":"Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy","volume":"39","author":"Krishna","year":"2021","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112259_bb0245","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41416-021-01389-8","article-title":"Phase 1 study of single-agent WNT974, a first-in-class porcupine inhibitor, in patients with advanced solid tumours","volume":"125","author":"Rodon","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112259_bb0250","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/oncolo\/oyad007","article-title":"A phase Ib\/II study of WNT974 + encorafenib + cetuximab in patients with BRAF V600E-mutant KRAS wild-type metastatic colorectal cancer","volume":"28","author":"Tabernero","year":"2023","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.cellsig.2025.112259_bb0255","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/cts.13287","article-title":"Model-based dose selection to inform translational clinical oncology development of WNT974, a first-in-class porcupine inhibitor","volume":"15","author":"Ji","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.cellsig.2025.112259_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104069","article-title":"Safety, tolerability, and anti-fibrotic efficacy of the CBP\/\u03b2-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: an investigator-initiated, open-label, non-randomised, multicentre, phase 1\/2a study","volume":"80","author":"Kimura","year":"2022","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112259_bb0265","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41416-020-0916-5","article-title":"First-in-human study of the PARP\/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor","volume":"123","author":"Plummer","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112259_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","article-title":"Targeting integrin pathways: mechanisms and advances in therapy","volume":"8","author":"Pang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2025.112259_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115669","article-title":"Selectivity of the collagen-binding integrin inhibitors, TC-I-15 and obtustatin","volume":"428","author":"Hunter","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112259_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010040","article-title":"Convection-enhanced delivery of a first-in-class anti-\u03b21 integrin antibody for the treatment of high-grade glioma utilizing real-time imaging","volume":"13","author":"Nwagwu","year":"2020","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112259_bb0285","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1158\/1535-7163.MCT-18-0953","article-title":"Enhancing therapeutic efficacy of oncolytic herpes simplex virus-1 with integrin \u03b21 blocking antibody OS2966","volume":"18","author":"Lee","year":"2019","journal-title":"Mol. Cancer Ther."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825006746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825006746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:20:12Z","timestamp":1766103612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825006746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":57,"alternative-id":["S0898656825006746"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112259","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COL1A1 promotes clear cell renal cell carcinoma progression through the Wnt\/\u03b2-catenin signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112259"}}